Summary
To evaluate the effect of combined kidney and pancreas transplantation on insulin action and glucose metabolism, 15 Type 1 (insulin-dependent) diabetic patients who were undergoing combined kidney-pancreas transplantation were studied before transplantation by means of the euglycaemic hyperinsulinaemic clamp technique combined with 3-3H-glucose infusion and indirect calorimetry. Nine of the original 15 patients were studied again after four months and six after 12 months, successful combined kidney-pancreas transplantation with the same experimental protocol. Nine volunteers formed the group of normal subjects. Combined kidney-pancreas transplantation normalised hepatic glucose production and reduced peripheral insulin resistance in Type 1 diabetic uraemic patients, despite chronic immunosuppressive therapy. To further evaluate the hypothesis that residual insulin resistance was due to chronic steroid therapy, 11 additional subjects with chronic uveitis (six of whom were treated with only prednisone, and five treated only with cyclosporin) underwent the same protocol demonstrating a normal hepatic glucose production. The insulin-stimulated peripheral glucose uptake was reduced in the prednisone-treated group, but normal in cyclosporin-treated subjects. Four additional diabetic patients with a kidney transplant were also studied. They showed a peripheral insulin sensitivity intermediate between diabetic uraemic patients and patients after combined transplant. We conclude that short-term (one year) combined kidney-pancreas transplantation improves glucose metabolism by restoring normal rates of hepatic glucose production and reducing peripheral insulin resistance; chronic steroid therapy is the major determinant of residual reduced insulin action. Both kidney and pancreas substitution play a role in reducing peripheral insulin resistance.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sutherland DER, Moudry K (1986) Pancreas transplant registry report. Transplant Proc 18: 1739–1746
Prieto M, Sutherland DER, Goetz FC, Rosenberg ME, Najarian JS (1987) Pancreas transplant results according to the technique of duct management: bladder versus enteric drainage. Surgery 102: 680–691
Dubernard JM, Traeger J, Neyra P, Touraine JL, Trenchant D, Blanc Brunat N (1978) A new method of preparation of segmental pancreatic graft for transplantation: trials in dogs and in man. Surgery 84: 633–639
Calne RJ (1984) Paratopic segmental pancreas grafting: a technique with portal venous drainage. Lancet I: 595–597
Groth GC, Collste H, Lundgren G, Wilczek H, Klintmalm G, Ringden O, Gunnarsson R, Östman J (1982) Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modification in technique. Lancet II: 522–524
Pozza G, Traeger J, Dubernard JM, Secchi A, Pontiroli AE, Bosi E, Malik MC, Ruitton A, Blanc N (1983) Endocrine responses of Type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia 24: 244–248
Sutherland DER, Najarian JS, Greensberg BZ, Senske BJ, Anderinon GE, Francis RS, Goetz FC (1981) Hormonal and metabolic effects of a pancreatic exocrine graft. Ann Int Med 95: 537–541
Pozza G, Bosi E, Secchi A, Piatti PM, Touraine JL, Gelet A, Pontiroli AE, Dubernard JM, Traeger J (1985) Metabolic control of type 1 (insulin-dependent) diabetes after pancreas transplantation. Br Med J 291: 510–513
Tyden G, Wilczec H, Lundgren G, Östman J, Gunnarsson R, Jarenko F, Groth G-C (1985) Experience with 21 intraperitoneal segmental pancreatic transplants with enteric or gastric exocrine diversion in humans. Transplant Proc 17: 331–335
Östman J, Bolinder J, Gunnasrsson R, Brattström C, Tyden G, Wahren J, Groth G-C (1989) Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes 38 [S 1]: 88–93
Landgraf R, Landgraf-Leur MMC, Burg D, Kampik A, Castro LA, Abendroth A, Illner WD, Land W (1986) Long-term follow up of segmental pancreas transplantation in Type 1 diabetes. Transplant Proc 18: 1118–1124
Sutherland DER (1988) Who should get a pancreas transplant? Diabetes Care 11: 681–685
Rizza R, Mandarino LJ, Gerich JE (1982) Cortisol induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect in insulin action. J Clin Endocrinol Metab 54: 131–138
Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'Omo AM, Imbimbo B (1983) An in vivo and in vitro study of the mechanism of prednisone — induced insulin resistance in healthy subjects. J Clin Invest 72: 1814–1820
Baron AD, Wallace P, Brechtel G (1987) In vivo regulation of non insulin-mediated and insulin-mediated glucose uptake by cortisol. Diabetes 36: 1230–1237
Abumrad NN, Rabin D, Diamond MP, Lacy WW (1981) Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 30: 936–940
Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jecquier E, Felber JP (1982) Effect of graded amounts of insulin on total glucose uptake, glucose oxidation and glucose storage in man. Diabetes 31: 957–963
Castellino P, Luzi L, Simonson DC, Haymond WM, DeFronzo RA (1987) Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. J Clin Invest 80: 1784–1793
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 232: E 214-E 233
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–430
Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628–634
Lusk G (1928) The elements of the science of nutrition. WB Saunders, Philadelphia
Hawk PD (1947) Kjeldhal method. In: Practical physiological chemistry 12th edn. Blakiston, Toronto, pp 814–822
Ripamonti M, Mosca A, Rovida E, Luzzana M, Luzi L, Ceriotti F, Cottini F, Rossi-Bernardi L (1984) Urea, creatinine and glucose determined in plasma and whole blood by a differential-pH technique. Clin Chem 30: 556–559
Novak M (1965) Colorimetric ultramicromethod for the determination of free fatty acids. J Lip Res 6: 431–433
Groop LC, Luzi L, Melander A, Groop P-H, Ratheiser K, Simonson DC, DeFronzo RA (1987) Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes 36: 1320–1328
DeFronzo RA, Hendler R, Simonson DC (1982) Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795–701
Del Prato S, Nosadini R, Tiengo A, Tessari P, Avogaro A, Trevisan R, Valerio A, Muggeo M, Cobelli C, Toffolo G (1983) Insulin-mediated glucose disposal in type 1 diabetes: evidence for insulin resistance. J Clin Endocrinol Metab 57: 904–910
Mondon C, Dolkas C, Reaven G (1978) The site of insulin resistance in acute uremia. Diabetes 27: 571–576
DeFronzo RA, Alvestrand A, Smith D, Hendler R, Wahren J (1987) Insulin resistance in uremia. J Clin Invest 79: 547–556
Del Prato S, Castellino P, Simonson DC, DeFronzo RA (1987) Hyperglucagonemia and insulin-mediated glucose metabolism. J Clin Invest 79: 547–556
McGorman LR, Rizza RA, Gerich JE (1981) Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab 53: 556–559
Rizza RA, Mandarino LJ, Gerich JE (1982) Effects of growth hormone on insulin action in man. Diabetes 31: 663–669
Deibert DC, DeFronzo RA (1980) Epinephrine-induced insulin resistance in man — a beta receptor mediated phenomenon. J Clin Invest 65: 717–721
Unger RH, Grundy S (1985) Hyperglycemia as an inducer, as well as a consequence of impaired islet cell function and insulin resistance: implication for the management of Diabetes. Diabetologia 28: 119–121
Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA (1987) Correction of hyperglycemia with phloridzin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79: 1510–1515
Tessari P, Inchiostro S, Biolo G, Duner E, Nosadini R, Tiengo A, Crepaldi G (1985) Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. Diabetologia 28: 870–872
Balasse EO (1971) Effect of free fatty acids and ketone bodies on glucose uptake and oxidation in the dog. Horm Metab Res 3: 403–409
Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA (1983) Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72: 1737–1747
McGarry JD, Foster DW (1972) Regulation of ketogenesis and clinical aspects of the ketotic state. Metabolism 21: 471–489
Luzi L, Barrett EJ, Groop LC, Ferrannini E, De Fronzo RA (1988) Metabolic effects of low-dose insulin therapy on diabetic ketoacidosis. Diabetes 37: 1470–1477
Quesniaux V, Tees R, Schreier MH, Mauer G, van Regen Moretel MHV (1987) Potential of monoclonal antibodies to improve therapeutic monitoring of cyclosporin. Clin Chem 33: 32–37
Ropers TA (1958) Inhibition of glucose uptake by acidosis in vitro. Proc Soc Exp Biol Med 97: 646–647
Bilbrey GL, Faloona GR, White MG, Knochel JP (1974) Hyperglucagonemia of renal failure. J Clin Invest 53: 841–847
Linn VS, Kathpalia SC, Henriquez C (1978) Endocrine abnormalities associated with chronic renal failure. Med Clin N Am 62: 1341–1344
Phillips LS, Kopple JD (1981) Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. Metabolism 30: 1091–1095
Emmanouel DS, Jaspan JB, Rubenstein AH, Fink AHH, Katz AI. Glucagon metabolism in the rat (1978) Contribution of the kidney to the metabolic clearance rate of the hormone. J Clin Invest 62: 6–13
Ringoir S, Schoots A, Vanholder R (1988) Uremic toxins. Kidney Int 33 [Suppl 24]: S4–9
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357
DeFronzo RA, Felig P (1980) Amino acid metabolism in uremia: insights gained from normal and diabetic man. Am J Clin Nutr 33: 1378–1386
Bagdade JD (1970) Uremic lipemia. An unrecognized abnormality in tryglyceride production and removal. Ann Intern Med 126: 875–881
May RC, Clark AS, Goheer MA, Mitch WE (1985) Specific defects in insulin-mediated muscle metabolism in acute uremia. Kidney Int 28: 490–497
Yki-Järvinen H, Koivisto V (1984) Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab 58: 659–666
Garvey WT, Olefsky JM, Griffin J, Hamman RF, Koltermann OG (1985) The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus. Diabetes 34: 222–234
DeFronzo RA, Tobin JD, Rowe JW, Andres R (1978) Glucose intolerance in uremia. Quantification of pancreatic β-cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425–435
La Rocca E, Dubernard JM, Samseverino R, Camozzi L, Faure JL, Lefrancois N, Martin X, Finaz J, Touraine JL (1987) Results of simultaneous pancreaticorenal transplantation — Lyon, France. Transplant Proc 19 [Suppl 4]: 44–47
Myers BD (1986) Cyclosporin nephrotoxicity. Kidney Int 30: 1964–1974
Gelfand AR, Matthews DM, Bier DM, Sherwin RS (1984) Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest 74: 2238–2248
Tomas FN, Munro HN, Young VR (1979) Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N-methylhistidine. Biochem J 178: 139–146
Baxter JD (1976) Glucocorticoid hormone action. Pharmacol Ther 2: 605–625
Cigolini M, Smith U (1979) Human adipose tissue in culture. VIII. Studies on the insulin-antagonistic effect of glucocorticoids. Metabolism 28: 502–510
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luzi, L., Secchi, A., Facchini, F. et al. Reduction of insulin resistance by combined kidney-pancreas transplantation in Type 1 (insulin-dependent) diabetic patients. Diabetologia 33, 549–556 (1990). https://doi.org/10.1007/BF00404143
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404143